Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-01 21:48:27 - browse：39

Mathai Mammen crosses his arms and looks into the camera — coverage from STAT — FogPharma CEO Mathai Mammen Boston Globe Photo Import

Oncology startup FogPharma just closed a $145 million Series E round, the company confirmed, reaching a late stage of financing that few other biotechs have hit in recent years.

FogPharma, which is headquartered in Cambridge, Mass., is developing cancer treatments using corkscrew-shaped peptides called helicons that could possibly better breach cells.

As CEO Mathai Mammen sees it, very few exemplary medicines shuttle off of drug companies’ pipelines, wade through clinical trials, and end up in the hands of physicians and patients in a given year. Far more often, pharma and biotech companies are pushing out drugs that are incrementally better than what came before, extending cancer patients’ survival by a few more months, halting their tumor growth for a little while longer. But FogPharma could deliver something truly unique, Mammen said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： 2023 Nobel Prize in Medicine goes to Karikó and Weissman

focus

WSS

What affirmative action's end means to a medical student

Being 'nonadherent' patient made me a more empathetic doctor

Being 'nonadherent' patient made me a more empathetic doctor

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Medicare innovation center doesn’t save money, experts say

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

hotspot

Wikipedia

focus

Alkermes shareholders re

How Robert F. Kennedy Jr. distorted vaccine science

In age of alternative facts, a scholarly course on calling out crap

Security flaws in third

United colonoscopy coverage change 'may cost lives,' doctors say

Undocumented workers face uncertainty as immigration law takes effect in Florida

Medicare details structure of new drug price negotiation program

Crowdfunding for unproven stem cell procedures spreads misinformation

In Memoriam: Notable people who died in 2023

What affirmative action's end means to a medical student

explore

A letter from the executive editor: The 2023 STATUS List

Use doctors trained outside the U.S. to ease the physician shortage

The stability of $0 premiums in Medicare Advantage

Congress extends some pandemic preparedness programs

6 solutions to address cancer drug shortages and others

CRISPR base editing slashes cholesterol levels in monkeys

focus

focus

focus

knowledge